Follow Us

Search

PICNet  >  Search results for "news word cleantalkorg2.ru cnn news news today in the world news today breaking news english search Finance cnn news" (Page 23)

2024-01-18 Slides_Throw it Away

[…] article: Mistry R, Russell RV, Walker N, Ofo E. The single-userhinolaryngoscope: an evaluation and costcomparison. J Laryngol Otol 2020; 134 : 790 –797. https://doi.org/10.1017/ S0022215120001656 Accepted: 29 April 2020First published online: 28 September 2020 Key words:Endoscopy; Otolaryngology;Costs And Cost Analysis Author for correspondence:Dr Rakesh Mistry,Department of Otolaryngology,St George ’s University Hospital, Blackshaw Road, London, SW17 0QT, UKE-mail: rakeshmistry@nhs.net Fax: +450 72 25 20 50 ©TheAuthor(s),2020.PublishedbyCambridge...

Type: Attachment

Andrea Vu Tran
Share

mmrv_qa_revised_sr_pdf1[1]

Measles, Mumps, Rubella and Varicella (MMRV) Vaccine Questions and Answ ers for Immunization Providers – December 2013 1. When was the MMRV vaccine authorized for use? 2. What is the intended use of MMRV vaccine in BC? 3. Who may receive the MMRV vaccine before July 2014? 4. What does the MMRV vaccine packaging look like? 5. How is the MMRV vaccine supplied? 6....

Type: Attachment

Picnet Admin
Share

QuadrivalentInfluenzaVaccineFactSheet_Aug29_Final

1 Quadrivalent Influenza Vaccine (QIV) Fact Sheet – 2014/15 1. What are quadrivalent influenza vaccine s? 2. Are quadrivalent influenza vaccine s recommended over trivalent influenza vaccine s, and will these be available in the publicly funded program in 2014/ 15? 3. Which quadrivalent influenza products are authorized for use in Canada , and which will be available for the...

Type: Attachment

Picnet Admin
Share

Module 5: Surveillance

Module 5: Surveillance Orientation Program for Infection Control Pr ofessionals Orientation Program for Infection Control Professionals ICP Orientation Program Page i Table of Contents Module 5: Surveillance ...

Type: Attachment

Picnet Admin
Share

PICNet-Annual-MRSA-Surveillance-Report-2013-2014

Methicillin -Resistant Staphylococcus aureus (MRSA) Surveillance Report For the Fiscal Year 201 3/20 14 (April 1, 201 3 to March 31, 201 4) Prepared by: Provincial Infection Control Network of British Columbia (PICNet) September 201 4 Provincial Infection Control Network of BC (PICNet) 1001 West Broadway, Suite 504 Vancouver, BC, V6H 4B1 www.picnet.ca Fax: 604 -875 -4373 Tel: 604 -875 -4844 ext 22983 Email: picnet@phsa.ca Disclaim er...

Type: Attachment

Picnet Admin
Share

Guideline Wound Bed Preparation 2015 June

British Columbia Prov incial Nursing Skin and Wound Committee Guideline: Wound Bed Preparat ion for Healable and Non Healable Wounds Note: This is a controlled document. A printed copy may not reflect the current, electronic version on the CLWK website. Any document appearing in paper form should always be checked against the electronic version prior to use; the electronic version is always the...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q1and2 2016_17

Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO) update January 201 7 Highlights for Q 1 and Q2 20 16/1 7 (April 1 – September 8 , 201 6)  43 new cases of CPO were identified amon g 39 patients in BC acute care facilities  NDM was the most common gene identified (29 /43 cases, 67.4 %)  31 cases (72.1 %) reported...

Type: Attachment

Picnet Admin
Share

PICNet_CPO_Public_Report_Q3_2016-17

Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO) update March 201 7 Highlights for Q 3 20 16/1 7 (September 9 – December 1 , 201 6)  12 new cases of CPO were identified amon g 11 patients in BC acute care facilities  NDM was the most common gene identified (10 /12 cases, 83.3 %)  8 cases (66.7 %) reported healthcare exposure...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q1 2017_18

Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO s) update November 201 7 Highlights for Q 1 20 17/1 8 (April 1 – June 16 , 2017 )  40 new cases of CPO were identified among 35 patients in BC acute care facilities  NDM was the most common gene identified (27 /40 cases, 67.5 %)  31 cases (77.5%) reported healthcare exposure outside...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q2 2017_18

Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO s) update January 2018 Highlights for Q 2 20 17/1 8 (June 1 6 – September 7, 2017 )  28 new cases of CPO were identified in 2 5 patients in BC acute care facilities .  The majority of new cases harbored the NDM resistance gene (20 , 7 1.4%) .  14...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q3 2017_18

Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO s) update March 2018 Highlights for Q 3 20 17/1 8 (September 8 – November 30 , 2017 )  11 new cases of CPO were identified in 11 patients in BC acute care facilities .  The NDM resistance gene accounted for the majority of cases (8, 72.7 %) .  4 cases (36.4...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q4 FY2017_18

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate August 2018 Highlights for Q 4 20 17/1 8 (Dec 1, 2017 – March 31, 2018 )  52 new cases of CPO were identified among 51 patients .  2 cases were reported in community healthcare setting s, including the first CPO case identified in the region of Northern Health. ...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report_Q1_2018-19

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate Novem be r 2018 Highlights for Q 1 2018/19 (Apr 1, 2018 – June 28 , 2018 )  75 carbapenemase resistance genes were newly identified from 68 isolates – 7 isolates harbor ed 2 differen t genes  The NDM resistance gene accounted for the majority of genes identified (68.0% ) ...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q2_2018-19

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate Decemb er 2018 Highlights for Q 2 2018/19 (June 29 – September 20 , 2018 )  66 carbapenemase resistance genes were newly identified from 6 3 isolates – 3 isolates harbor ed 2 differen t genes  The NDM resistance gene accounted for the majority of genes identified (63.6 %)  Surveillance...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q3_2018-19

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate March 201 9 Highlights for Q 3 2018/19 (September 21 – December 13 , 2018 )  63 carbapenemase resistance genes were newly identified from 59 isolates – 4 isolates harbo ured 2 differen t genes  The NDM resistance gene accounted for the majority of genes identified (69.8 %)  Surveillance <mark...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q4_2018-19

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate July 201 9 Highlights for Q 4 2018/19 (December 1 4, 2018 – March 31, 2019 )  70 carbapenemase resistance genes were newly identified from 64 isolates – 6 isolates harbo ured 2 differen t genes  The NDM resistance gene accounted for the majority of genes identified (42/70, 60.0 %) ...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q1_2019-20 updated

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate October 201 9 Highlights for Q 1 of 201 9/20 (April 1 – June 27 , 2019 )  83 carbapenemase genes were newly identified from 80 isolates – 3 isolates harbo ured 2 differen t genes  NDM were predominant in the carbapenemase genes identified (45/83 , 54.2 %)  Surveillance information...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q2_2019-20

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate December 201 9 Highlights for Q 2 of 201 9/20 (June 28 – September 19 , 2019 )  41 patients were newly confirmed with CPO  46 new cases of carbapenemase genes were identified , including 5 patients each ha ving 2 or more differen t genes  NDM were the most...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q3&4_2019-20

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate September 2020 Highlights for Q 3 & Q4 of 201 9/20 (September 20 , 2019 – March 31 , 20 20 )  153 patients were newly confirmed with CPO  168 cases of carbapenemase were newly identified , including 15 patients each ha ving 2 differen t carbapenemase genes  NDM was <mark...

Type: Attachment

Picnet Admin
Share

PICNet_CPO Public Report Q1-Q3_2020-21_corrected

Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate June 9 , 202 1 Highlights for Q 1 – Q3 of 20 20 /21 (April 1 – December 10 , 20 20 )  94 patients were newly confirmed with CPO s, including 2 patients who each had 2 different carbapenemase gene s  Each gene newly identified is considered a new case,...

Type: Attachment

Picnet Admin
Share